0000950170-23-070510.txt : 20231214
0000950170-23-070510.hdr.sgml : 20231214
20231214183501
ACCESSION NUMBER: 0000950170-23-070510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231214
DATE AS OF CHANGE: 20231214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ketchum Steven B
CENTRAL INDEX KEY: 0001289884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 231488367
MAIL ADDRESS:
STREET 1: 2483 EAST BAYSHORE ROAD
STREET 2: SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
ownership.xml
4
X0508
4
2023-12-12
0000897448
AMARIN CORP PLC\UK
AMRN
0001289884
Ketchum Steven B
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
false
true
false
false
Chief Scientific Officer
true
Ordinary Shares
2023-12-12
4
S
false
34131
0.79
D
566100
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.78 to $0.8055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
s/ Tom Reilly, by power of attorney
2023-12-14